Search

In this brief, we explore avenues for expanding hormonal contraceptive care and supplies through pharmacies, as well as how and where pharmacies and pharmacists may be positioned to fill gaps in contraceptive care where there are few brick-and-mortar family planning providers, as well as the challenges in expanding these pathways.

Akash Pillai is a policy analyst with KFF’s Program on Medicaid and the Uninsured and Racial Equity and Health Policy. Prior to joining KFF, he worked with the Community Healthcare Association of New York State on health policy projects supporting New York’s Federally Qualified Health Centers. He also conducted population…

In his latest column, KFF President and CEO Drew Altman explains why Medicaid, despite former President Donald Trump’s silence on the topic, warrants greater attention given the potential for drastic changes or cuts to it should Republicans win control in the election.

Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations, according to a new analysis. The most used drug for people with employer-sponsored health insurance was Jardiance, a drug used to treat diabetes and…

With the 2024 election season underway, a large majority of the public reports hearing false claims about immigrants from candidates or elected officials, and many immigrants say Donald Trump’s rhetoric in particular is negatively affecting how they are treated. This poll finding also gauges understanding about U.S. immigrants’ eligibility for government benefits programs.

KFF is a nonprofit organization focused on health policy. We conduct our own research, polling, journalism, and specialized public health information campaigns.  We’re unique in the way we bring together these different areas to create and communicate information about health policy to a variety of audiences. We do everything based…

This analysis examines who was eligible for Medicare and/or Medicaid between 2002 and 2022 because they received disability benefits from one of the country’s Social Security disability programs, Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI). Many who receive SSDI and SSI qualify for both Medicare and Medicaid, known as dual-eligible individuals.

There were gains in coverage across most racial and ethnic groups between 2019 and 2023 after several years of rising uninsured rates during the first Trump administration. The coverage gains between 2019 and 2023 were largely driven by increases in Medicaid coverage, reflecting policies to stabilize and expand access to affordable coverage that were implemented during the COVID-19 pandemic.